Literature DB >> 22489352

Vismodegib granted FDA approval for treatment of basal cell carcinoma.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22489352

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  5 in total

Review 1.  Cholesterol and its derivatives in Sonic Hedgehog signaling and cancer.

Authors:  Natalia A Riobo
Journal:  Curr Opin Pharmacol       Date:  2012-07-23       Impact factor: 5.547

2.  Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity.

Authors:  Duhyeong Hwang; Taylor Dismuke; Andrey Tikunov; Elias P Rosen; John R Kagel; Jacob D Ramsey; Chaemin Lim; William Zamboni; Alexander V Kabanov; Timothy R Gershon; Marina Sokolsky-Papkov PhD
Journal:  Nanomedicine       Date:  2020-11-28       Impact factor: 5.307

3.  DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach.

Authors:  Marie Loh; Natalia Liem; Aparna Vaithilingam; Pei Li Lim; Nur Sabrina Sapari; Eiram Elahi; Zuan Yu Mok; Chee Leong Cheng; Benedict Yan; Brendan Pang; Manuel Salto-Tellez; Wei Peng Yong; Barry Iacopetta; Richie Soong
Journal:  BMC Gastroenterol       Date:  2014-03-28       Impact factor: 3.067

4.  Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy.

Authors:  Ashley E Ross; Robert M Hughes; Stephanie Glavaris; Kamyar Ghabili; Ping He; Nicole M Anders; Rana Harb; Jeffrey J Tosoian; Luigi Marchionni; Edward M Schaeffer; Alan W Partin; Mohamad E Allaf; Trinity J Bivalacqua; Carolyn Chapman; Tanya O'Neal; Angelo M DeMarzo; Paula J Hurley; Michelle A Rudek; Emmanuel S Antonarakis
Journal:  Oncotarget       Date:  2017-10-26

Review 5.  Emerging agents that target signaling pathways in cancer stem cells.

Authors:  Yue Yang; Xiaoman Li; Ting Wang; Qianqian Guo; Tao Xi; Lufeng Zheng
Journal:  J Hematol Oncol       Date:  2020-05-26       Impact factor: 17.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.